PEGINESATIDE ACETATE
| Brand name | OMONTYS |
|---|---|
| Active ingredient | PEGINESATIDE ACETATE |
| Strength | EQ 10MG BASE/ML (EQ 10MG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS, SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | March 2012 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7550433 | June 2026 | use U-1238 |
| 7919461 | June 2026 | use U-1238 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.